BBR improves mouse endothelial function and alleviates atherosclerosis by inhibiting p38 MAPK and c-Jun N-terminal kinase (JNK) signaling pathways and downregulating adiponectin expression (Wan et al., 2018). This evidence concerns the gene ADIPOQ and atherosclerosis.